Latest news about Adeshwar Meditex
Adeshwar Meditex
16.80
-0.15(-0.88%)
Company Performance:
View Company Insights1D-0.88%
1M0.00%
6M0.00%
1Y+0.72%
5Y-43.81%
More news about Adeshwar Meditex
21May 26
Adeshwar Meditex FY26 net profit at Rs 126.49 lakh
Adeshwar Meditex announced its audited financial results for the year ended March 31, 2026, reporting a net profit of Rs 126.49 lakh on revenue of Rs 5,610.38 lakh. The board approved the appointment of Ms. Bhagyalaxmi Kavital as an Additional Independent Director and discussed fund raising plans of up to Rs 40 Crores. The trading window closure will end 48 hours post-results announcement.
14May 26
Adeshwar Meditex Reappoints M/s. Basude Makote & Saini as Internal Auditors for FY 2025-26 to 2027-28
Adeshwar Meditex Limited's Board of Directors approved the reappointment of M/s. Basude Makote & Saini, Chartered Accountants (FRN No. 124381W), as Internal Auditors for FY 2025-26 to 2027-28 at its meeting on May 14, 2026. The firm has been serving as Internal Auditor since August 26, 2023, and the reappointment was made under Section 138 of the Companies Act, 2013. The disclosure was filed with BSE Limited under Regulation 30 of the SEBI (LODR) Regulations, 2015. The board meeting was held from 4:00 PM to 4:30 PM (IST) and was authorized by Whole-time Director Krishnojirao Nagaraja Rao.
08Apr 26
Adeshwar Meditex Limited Files SEBI Compliance Disclosure for Quarter Ended March 31, 2026
Adeshwar Meditex Limited filed its quarterly SEBI compliance disclosure for Q4 FY26, confirming no dematerialisation requests were received from January to March 2026. The disclosure was submitted to BSE Limited on April 8, 2026, under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, with certification from RTA Bigshare Services Pvt. Ltd.
07Apr 26
Adeshwar Meditex Limited Files Annual SEBI Disclosure Under Takeover Regulations for FY26
Adeshwar Meditex Limited submitted its annual SEBI disclosure for FY26, confirming no share encumbrance by promoters during the year. Promoters Krishnojirao Nagaraja Rao and Abhinandan Nagaraja Rao hold 40,12,000 and 43,11,332 shares respectively as of March 31, 2026. The disclosure was filed with BSE under Regulation 31(4) of SEBI takeover regulations, ensuring compliance with substantial shareholding requirements.
20Dec 25
Adeshwar Meditex Appoints New Independent Director and Reconstitutes Committees
Adeshwar Meditex Limited has made significant governance changes by appointing Mr. Raghupathy Bhat, a seasoned professional with 40+ years of experience, as Additional Non-Executive Independent Director. The company has also reconstituted its Audit, Nomination and Remuneration, and Stakeholder Relationship Committees to reflect the new board composition, with an EGM scheduled for January 20, 2025, to seek shareholder approval.
31Oct 25
Adeshwar Meditex Reports Passing of Independent Director, Mr. Benegal Parameshwara Udpa
Adeshwar Meditex Limited reported the death of Mr. Benegal Parameshwara Udpa, a Non-Executive Independent Director, on October 22, 2025. The company was informed on October 28, 2025, and immediately notified BSE. A clarification was provided to BSE on October 30, 2025, explaining the delay in announcement due to late communication from the director's family.
28Oct 25
Adeshwar Meditex Mourns the Loss of Independent Director Benegal Parameshwara Udpa
Adeshwar Meditex Limited has reported the demise of Mr. Benegal Parameshwara Udpa, a Non-Executive Independent Director, on October 22, 2025. Mr. Udpa, who joined the board on June 30, 2023, was recognized for his significant contributions, including active participation in meetings, valuable guidance, and dedicated service. The company's board expressed deep appreciation for his work and conveyed condolences to his family, acknowledging the loss as irreparable.
25Oct 25
Adeshwar Meditex Appoints New Statutory Auditor Following Resignation
Adeshwar Meditex Limited's Board of Directors has approved the appointment of M/s. Rajesh H. Gupta & Co. as the new statutory auditor, effective October 24, 2025. This decision follows the resignation of the previous auditor, M/s. J N Gupta & Co. LLP. The new auditor's term will last until the conclusion of the next Annual General Meeting, subject to shareholder approval. M/s. Rajesh H. Gupta & Co. is a professionally managed firm with expertise in various financial services. The appointment complies with SEBI regulations, and the company has informed the BSE Limited of this change.
Industry Peers
Syngene International
Indegene
Suven Life Sciences
Vimta Labs
TAKE
Bilcare
Jeevan Scientific TechnologyAdeshwar Meditex
Vanta Bioscience
398.60
(-0.86%)
600.15
(-0.87%)
372.85
(-2.29%)
655.35
(-0.97%)
13.86
(-4.94%)
87.04
(-0.25%)
74.75
(+2.27%)
16.80
(-0.88%)
19.64
(0.0%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
